SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 6.14 |
| Enterprise Value ($M) | 9.20 |
| Book Value ($M) | -1.55 |
| Book Value / Share | -0.07 |
| Price / Book | -3.96 |
| NCAV ($M) | -3.86 |
| NCAV / Share | -0.18 |
| Price / NCAV | -1.59 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.59 |
| Return on Assets (ROA) | -0.61 |
| Return on Equity (ROE) | -2.00 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.11 |
| Current Ratio | 1.11 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1.00 |
| Assets | 3.31 |
| Liabilities | 4.86 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 22,137 | 217,767 | 10.17 | |
| 1,510 | 215,907 | 0.70 | |
| 4,103 | 64,824 | 6.33 | |
| 31,554 | 152,964 | 20.63 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IXHL – Incannex Healthcare Inc. | JANX – Janux Therapeutics, Inc. |
| KALV – KalVista Pharmaceuticals, Inc. | KOD – Kodiak Sciences Inc. |
| KROS – Keros Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io